Company: RGNX
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001193125-25-174953
Chunk: 11

Company: REGENXBIO Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 6
Chunk 11
---
Incorporated by Reference

     ExhibitNumber
      
     Description
      
     Form
      
     ExhibitNumber
      
     Filing Date
      
     Filed orFurnishedHerewith

       3.1
      
     Restated Certificate of Incorporation
      
     8-K
      
     3.1
      
     6/7/21

       3.2
      
     Amended and Restated Bylaws
      
     8-K
      
     3.2
      
     9/22/15

       4.1
      
     REGENXBIO Inc. Warrant to Purchase Common Stock
      
     S-3
      
     4.5
      
     6/13/25

     10.1*
      
     REGENXBIO Inc. 2025 Equity Incentive Plan
      
     S-8
      
     99.1
      
     6/13/25

     10.2*
      
     Form of Restricted Stock Unit Award Agreement for the 2025 Equity Incentive Plan

     X

     10.3*
      
     Form of Stock Option Award Agreement for the 2025 Equity Incentive Plan

     X

     10.4†
      
     Loan Agreement dated May 16, 2025 between REGENXBIO RS LLC and affiliate of HealthCare Royalty Management, LLC

     X

     31.1
      
     Certification of the Chief Executive Officer as required by Section 302 of the Sarbanes-Oxley Act of 2002

     X

     31.2
      
     Certification of the Chief Financial Officer as required by Section 302 of the Sarbanes-Oxley Act of 2002

     X

     32.1
      
     Certifications of the Chief Executive Officer and Chief Financial Officer as required by 18 U.S.C. 1350

     X

     101
      
     The following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025 formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets(ii) Consolidated Statements of Operations and Comprehensive Loss(iii) Consolidated Statements of Stockholders’